Open access
6,787
Views
5
CrossRef citations to date
0
Altmetric
Review Article
Real-world evidence for ixekizumab in the treatment of psoriasis and psoriatic arthritis: literature review 2016–2021
Adam Reicha Department of Dermatology, University of Rzeszów, Rzeszów, PolandView further author information
, Catherine Reedb Eli Lilly and Company Limited, Bracknell, UKCorrespondence[email protected]
View further author information
, View further author information
Christopher Schusterc Eli Lilly and Company, Vienna, AustriaView further author information
, Camille Robertd Lilly France, Neuilly Sur Seine, FranceView further author information
, Tamas Treuere Lilly Hungária Kft, Budapest, HungaryView further author information
& Ennio Lubranof Internal Medicine and Rheumatology Unit, University of Molise, Campobasso, ItalyView further author information
Article: 2160196
|
Received 26 Oct 2022, Accepted 11 Dec 2022, Published online: 20 Jan 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.